SCHEMBL18200701

SCHEMBL18200701

c1ccc2c(-c3c4ccccc4c(-c4cccc5ccccc45)c4cc(-c5cnc(-c6nc7ccccc7c7c6ccc6ccccc67)c6ccccc56)ccc34)cccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MCL1 Q07820 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
ACVR1 Q04771 2/20 0.32
SOS1 Q07889 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
CYP2B6 P20813 1/20 0.32
CYP2C19 P33261 1/20 0.32
MET P08581 1/20 0.31
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31
ALDH1A1 P00352 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200695 0.86 ADORA2A (0.45) ADORA2AADORA1CYP1A2CYP3A4CYP2D6
SCHEMBL18200494 0.85 MEN1 (0.39) MEN1KMT2AMCL1ACMSDADORA2A
SCHEMBL18200718 0.84 TOP2A (0.36) MEN1KMT2ACYP1A2ALDH1A1MAPT
SCHEMBL18201248 0.84 MEN1 (0.38) MEN1KMT2AADORA2ASOS1CA12
SCHEMBL18200571 0.83 MEN1 (0.37) MEN1KMT2ASOS1METCA12
SCHEMBL18200698 0.83 MEN1 (0.37) MEN1KMT2ASOS1METCA12
SCHEMBL18200705 0.83 MAPT (0.41) MEN1KMT2AADORA2AADORA1ALDH1A1
SCHEMBL18200927 0.82 PIM1 (0.37) MEN1KMT2AMCL1ACMSDADORA2A
SCHEMBL18200751 0.82 ACVR1 (0.37) MEN1KMT2AMCL1ACMSDACVR1
SCHEMBL18200581 0.81 MAPT (0.35) MEN1KMT2ACYP1A2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MEN1 1750/4885KMT2A 1104/4885MCL1 2097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.